These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 1748434

  • 41. Histochemical and ultrastructural changes induced by zidovudine in mitochondria of rat cardiac muscle.
    Corcuera Pindado MT, Lopez Bravo A, Martinez-Rodriguez R, Picazo Talavera A, Gomez Aguado F, Roldan Contreras M, Perez Alvarez MJ, Fernandez Garcia A, Alonso Martin MJ.
    Eur J Histochem; 1994; 38(4):311-8. PubMed ID: 7535128
    [Abstract] [Full Text] [Related]

  • 42. Mitochondrial diseases and myopathies: a series of muscle biopsy specimens with ultrastructural changes in the mitochondria.
    Lindal S, Lund I, Torbergsen T, Aasly J, Mellgren SI, Borud O, Monstad P.
    Ultrastruct Pathol; 1992; 16(3):263-75. PubMed ID: 1316655
    [Abstract] [Full Text] [Related]

  • 43. Fetal patas monkeys sustain mitochondrial toxicity as a result of in utero zidovudine exposure.
    Gerschenson M, Poirier MC.
    Ann N Y Acad Sci; 2000 Nov; 918():269-81. PubMed ID: 11131713
    [Abstract] [Full Text] [Related]

  • 44. Retroviruses and inflammatory myopathies in humans and primates.
    Dalakas MC.
    Baillieres Clin Neurol; 1993 Nov; 2(3):659-91. PubMed ID: 8156147
    [Abstract] [Full Text] [Related]

  • 45. Mitochondrial and cellular toxicity induced by fialuridine in human muscle in vitro.
    Semino-Mora C, Leon-Monzon M, Dalakas MC.
    Lab Invest; 1997 Apr; 76(4):487-95. PubMed ID: 9111511
    [Abstract] [Full Text] [Related]

  • 46. Clinical, histological and molecular reversibility of zidovudine myopathy.
    Masanés F, Barrientos A, Cebrián M, Pedrol E, Miró O, Casademont J, Grau JM.
    J Neurol Sci; 1998 Aug 14; 159(2):226-8. PubMed ID: 9741412
    [Abstract] [Full Text] [Related]

  • 47. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
    Divi RL, Leonard SL, Kuo MM, Nagashima K, Thamire C, St Claire MC, Wade NA, Walker VE, Poirier MC.
    Environ Mol Mutagen; 2007 Aug 14; 48(3-4):201-9. PubMed ID: 16538687
    [Abstract] [Full Text] [Related]

  • 48. Zidovudine (AZT) causes an oxidation of mitochondrial DNA in mouse liver.
    de la Asunción JG, del Olmo ML, Sastre J, Pallardó FV, Viña J.
    Hepatology; 1999 Mar 14; 29(3):985-7. PubMed ID: 10051507
    [Abstract] [Full Text] [Related]

  • 49. [Clinical characteristics and ultra-structural features of skeletal muscle in mitochondrial cytopathies].
    Zhang ZQ, Sun YL, Niu ST, Liang XH, Wang YJ.
    Zhonghua Yi Xue Za Zhi; 2009 May 05; 89(17):1185-8. PubMed ID: 19595083
    [Abstract] [Full Text] [Related]

  • 50. [Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine].
    Charton-Bain MC, Flamant M, Aubertin JM, Belair MF, Gilquin J, Kazatchkine M, Bruneval P.
    Gastroenterol Clin Biol; 1997 May 05; 21(12):979-81. PubMed ID: 9587562
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. AZT myopathy and HIV-1 polymyositis: one disease or two?
    Walsh K, Kaye K, Demaerschalk B, Stewart S, Crukley J, Hammond R.
    Can J Neurol Sci; 2002 Nov 05; 29(4):390-3. PubMed ID: 12463497
    [Abstract] [Full Text] [Related]

  • 53. Erythrocebus patas monkey offspring exposed perinatally to NRTIs sustain skeletal muscle mitochondrial compromise at birth and at 1 year of age.
    Divi RL, Leonard SL, Walker BL, Kuo MM, Shockley ME, St Claire MC, Nagashima K, Harbaugh SW, Harbaugh JW, Poirier MC.
    Toxicol Sci; 2007 Sep 05; 99(1):203-13. PubMed ID: 17545213
    [Abstract] [Full Text] [Related]

  • 54. Genotoxicity and mitochondrial damage in human lymphocytic cells chronically exposed to 3'-azido-2',3'-dideoxythymidine.
    Agarwal RP, Olivero OA.
    Mutat Res; 1997 May 23; 390(3):223-31. PubMed ID: 9186571
    [Abstract] [Full Text] [Related]

  • 55. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
    Chariot P, Monnet I, Gherardi R.
    Ann Neurol; 1993 Oct 23; 34(4):561-5. PubMed ID: 8215243
    [Abstract] [Full Text] [Related]

  • 56. [Muscular involvement in HIV infection].
    Gherardi R, Chariot P, Authier FJ.
    Rev Neurol (Paris); 1995 Nov 23; 151(11):603-7. PubMed ID: 8745623
    [Abstract] [Full Text] [Related]

  • 57. Zidovudine therapy and myopathies associated with human immunodeficiency virus infection.
    Chariot P, Ruet E, Gherardi R.
    Ann Neurol; 1994 Feb 23; 35(2):247-8. PubMed ID: 8109910
    [No Abstract] [Full Text] [Related]

  • 58. Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine.
    Gerschenson M, Erhart SW, Paik CY, St Claire MC, Nagashima K, Skopets B, Harbaugh SW, Harbaugh JW, Quan W, Poirier MC.
    AIDS Res Hum Retroviruses; 2000 May 01; 16(7):635-44. PubMed ID: 10791874
    [Abstract] [Full Text] [Related]

  • 59. Mitochondrial myopathy caused by long-term zidovudine therapy.
    Gold R, Meurers B, Reichmann H.
    N Engl J Med; 1990 Oct 04; 323(14):994. PubMed ID: 2402267
    [No Abstract] [Full Text] [Related]

  • 60. [A clinical, histochemical and ultrastructural study of mitochondrial myopathy].
    Jiang XM.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Oct 04; 23(5):297-9, 320. PubMed ID: 2178086
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.